Voyageur Pb Ratio vs Free Cash Flow Yield Analysis

VM Stock  CAD 0.07  0.01  8.33%   
Voyageur Pharmaceuticals financial indicator trend analysis is much more than just breaking down Voyageur Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Voyageur Pharmaceuticals is a good investment. Please check the relationship between Voyageur Pharmaceuticals Pb Ratio and its Free Cash Flow Yield accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pb Ratio vs Free Cash Flow Yield

Pb Ratio vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Voyageur Pharmaceuticals Pb Ratio account and Free Cash Flow Yield. At this time, the significance of the direction appears to have no relationship.
The correlation between Voyageur Pharmaceuticals' Pb Ratio and Free Cash Flow Yield is 0.06. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Voyageur Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Voyageur Pharmaceuticals' Pb Ratio and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of Voyageur Pharmaceuticals are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Pb Ratio i.e., Voyageur Pharmaceuticals' Pb Ratio and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.06
Relationship DirectionPositive 
Relationship StrengthInsignificant

Pb Ratio

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.
Most indicators from Voyageur Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Voyageur Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Voyageur Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 11.97 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.2 M in 2024.

Voyageur Pharmaceuticals fundamental ratios Correlations

0.760.930.1-0.03-0.030.480.950.70.15-0.940.920.680.940.380.310.920.780.40.510.940.91-0.87-0.88-0.040.89
0.760.50.45-0.28-0.280.670.720.97-0.08-0.70.550.480.590.570.660.840.920.190.590.630.89-0.82-0.760.470.85
0.930.5-0.150.160.160.240.870.40.3-0.890.930.580.950.240.10.820.520.530.380.910.79-0.77-0.83-0.280.76
0.10.45-0.15-0.96-0.960.260.310.47-0.88-0.250.130.460.13-0.020.10.280.50.070.310.230.25-0.31-0.230.430.33
-0.03-0.280.16-0.961.0-0.14-0.27-0.310.950.23-0.13-0.53-0.130.170.11-0.21-0.37-0.01-0.3-0.22-0.150.160.12-0.19-0.18
-0.03-0.280.16-0.961.0-0.14-0.27-0.310.950.23-0.13-0.53-0.130.170.11-0.21-0.37-0.01-0.3-0.22-0.150.160.12-0.19-0.18
0.480.670.240.26-0.14-0.140.360.750.12-0.290.150.30.280.410.570.460.74-0.140.70.270.52-0.48-0.330.260.52
0.950.720.870.31-0.27-0.270.360.66-0.13-0.980.960.820.950.20.140.920.770.40.460.990.88-0.84-0.85-0.060.85
0.70.970.40.47-0.31-0.310.750.66-0.12-0.630.460.520.510.550.670.780.94-0.010.560.560.83-0.71-0.610.450.76
0.15-0.080.3-0.880.950.950.12-0.13-0.120.11-0.04-0.440.010.320.28-0.04-0.170.060.01-0.10.03-0.03-0.07-0.140.01
-0.94-0.7-0.89-0.250.230.23-0.29-0.98-0.630.11-0.96-0.8-0.96-0.24-0.14-0.94-0.72-0.42-0.44-0.98-0.90.820.850.12-0.83
0.920.550.930.13-0.13-0.130.150.960.46-0.04-0.960.750.970.12-0.010.860.590.510.330.980.8-0.77-0.83-0.210.77
0.680.480.580.46-0.53-0.530.30.820.52-0.44-0.80.750.74-0.04-0.10.710.61-0.020.450.820.63-0.45-0.45-0.340.48
0.940.590.950.13-0.13-0.130.280.950.510.01-0.960.970.740.220.080.890.670.510.440.970.84-0.81-0.85-0.230.81
0.380.570.24-0.020.170.170.410.20.550.32-0.240.12-0.040.220.940.40.550.10.290.140.51-0.49-0.440.380.51
0.310.660.10.10.110.110.570.140.670.28-0.14-0.01-0.10.080.940.340.59-0.020.350.040.47-0.46-0.380.590.49
0.920.840.820.28-0.21-0.210.460.920.78-0.04-0.940.860.710.890.40.340.820.380.530.890.99-0.86-0.850.040.88
0.780.920.520.5-0.37-0.370.740.770.94-0.17-0.720.590.610.670.550.590.820.130.560.680.86-0.8-0.70.310.84
0.40.190.530.07-0.01-0.01-0.140.4-0.010.06-0.420.51-0.020.510.1-0.020.380.130.050.440.36-0.66-0.70.190.6
0.510.590.380.31-0.3-0.30.70.460.560.01-0.440.330.450.440.290.350.530.560.050.430.53-0.46-0.51-0.030.48
0.940.630.910.23-0.22-0.220.270.990.56-0.1-0.980.980.820.970.140.040.890.680.440.430.84-0.8-0.83-0.180.8
0.910.890.790.25-0.15-0.150.520.880.830.03-0.90.80.630.840.510.470.990.860.360.530.84-0.88-0.860.130.9
-0.87-0.82-0.77-0.310.160.16-0.48-0.84-0.71-0.030.82-0.77-0.45-0.81-0.49-0.46-0.86-0.8-0.66-0.46-0.8-0.880.96-0.34-1.0
-0.88-0.76-0.83-0.230.120.12-0.33-0.85-0.61-0.070.85-0.83-0.45-0.85-0.44-0.38-0.85-0.7-0.7-0.51-0.83-0.860.96-0.21-0.95
-0.040.47-0.280.43-0.19-0.190.26-0.060.45-0.140.12-0.21-0.34-0.230.380.590.040.310.19-0.03-0.180.13-0.34-0.210.35
0.890.850.760.33-0.18-0.180.520.850.760.01-0.830.770.480.810.510.490.880.840.60.480.80.9-1.0-0.950.35
Click cells to compare fundamentals

Voyageur Pharmaceuticals Account Relationship Matchups

Voyageur Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.3M2.6M2.1M2.2M2.5M2.6M
Total Current Liabilities910.3K621.1K591.3K673.9K775.0K418.5K
Total Stockholder Equity306.3K1.9M1.5M1.4M1.7M1.7M
Net Debt265.4K(770.9K)(6.0K)37.9K43.6K45.8K
Cash3.0K813.0K31.6K2.1K1.9K1.8K
Cash And Short Term Investments3.0K813.0K31.6K2.1K1.9K1.8K
Net Receivables12.7K41.5K23.9K35.9K41.3K35.5K
Common Stock Shares Outstanding70.5M94.7M107.8M130.5M150.1M157.6M
Liabilities And Stockholders Equity1.3M2.6M2.1M2.2M2.5M2.6M
Total Liab968.8K660.6K630.8K727.9K837.1K484.9K
Total Current Assets25.5K887.3K157.2K88.6K101.9K96.8K
Retained Earnings(3.9M)(6.0M)(7.7M)(9.1M)(8.2M)(7.8M)
Other Stockholder Equity791.1K1.6M1.6M1.9M2.1M2.2M
Other Current Liab49.1K24.0K1.0673.7K774.7K813.4K
Net Tangible Assets515.7K754.1K306.3K1.9M2.2M2.3M
Property Plant And Equipment Net1.2M1.7M1.9M5.8K6.7K6.4K
Accounts Payable662.4K584.7K591.3K218.01250.71238.18
Non Current Assets Total1.2M1.7M1.9M2.1M2.4M1.3M
Other Current Assets12.6723.1K91.4K76.2K87.7K61.2K
Common Stock3.4M6.3M7.6M8.7M10.0M10.5M
Property Plant Equipment1.0M1.2M1.2M1.7M1.9M974.4K
Non Current Liabilities Total38.1K58.5K39.5K54K48.6K46.2K
Short Long Term Debt Total268.4K42.1K25.5K40K36K34.2K
Net Invested Capital545.3K1.9M1.5M1.5M1.7M1.1M
Net Working Capital(884.8K)266.2K(434.1K)(585.2K)(673.0K)(706.7K)
Short Term Debt8.6K114.5K223.9K16.6K19.0K18.1K
Capital Stock3.4M6.3M7.6M8.7M10.0M5.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Voyageur Stock Analysis

When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.